QQ客服 官方微博 反馈留言

	Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS-mediated PI3K/AKT signaling pathway
	Ma, Zhongbing; Liu, Xingli; Zhang, Qiang; Yu, Zhigang; Gao, Dezong
刊名	ONCOLOGY REPORTS
	2019
卷号	41期号:2页码:811-818
关键词	carvedilol cancer prevention reactive oxygen species phosphoinositide 3-kinase protein kinase B signaling pathway
DOI	10.3892/or.2018.6873
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4530013
专题	山东大学
作者单位	1.Shandong Univ, Hosp 2, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China. 2.[Liu, Xingl
推荐引用方式 GB/T 7714	Ma, Zhongbing,Liu, Xingli,Zhang, Qiang,et al. Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS-mediated PI3K/AKT signaling pathway[J]. ONCOLOGY REPORTS,2019,41(2):811-818.
APA	Ma, Zhongbing,Liu, Xingli,Zhang, Qiang,Yu, Zhigang,&Gao, Dezong.(2019).Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS-mediated PI3K/AKT signaling pathway.ONCOLOGY REPORTS,41(2),811-818.
MLA	Ma, Zhongbing,et al."Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS-mediated PI3K/AKT signaling pathway".ONCOLOGY REPORTS 41.2(2019):811-818.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。